And research by Tongyan et al. showed that in LUAD, CAFs mediate the upregulation of SLC38A2 through the lncRNA LINC01614, interacting with tumor cells to result in poor clinical outcomes (Liu et al., 2022). The gene discussed is SLC38A2; the disease is neoplasm.